D.E. Shaw & Co

D.E. Shaw & Co’s Keros Therapeutics KROS Stock Holding History

D.E. Shaw & Co’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.63M	Sell	509,608 -245,865	-33%	-$3.8M	﹤0.01%	2089
2025 Q4	$15.4M	Sell	755,473 -575,952	-43%	-$10.1M	0.01%	1419
2025 Q3	$21.1M	Buy	1,331,425 +34,042	+3%	+$503K	0.02%	1152
2025 Q2	$17.3M	Buy	1,297,383 +34,253	+3%	+$462K	0.02%	1126
2025 Q1	$12.9M	Buy	1,263,130 +1,251,031	+10,340%	+$14.5M	0.02%	1216
2024 Q4	$192K	Sell	12,099 -174,189	-94%	-$9.05M	﹤0.01%	4096
2024 Q3	$10.8M	Buy	186,288 +10,593	+6%	+$523K	0.01%	1380
2024 Q2	$8.03M	Buy	175,695 +156,821	+831%	+$8.43M	0.01%	1475
2024 Q1	$1.25M	Buy	+18,874	New	+$1.12M	﹤0.01%	2946
2023 Q2	–	Sell	-31,032	Closed	-$1.33M	–	4419
2023 Q1	$1.33M	Buy	+31,032	New	+$1.57M	﹤0.01%	2968
2022 Q3	–	Sell	-21,056	Closed	-$582K	–	5380
2022 Q2	$582K	Buy	+21,056	New	+$924K	﹤0.01%	4011
2021 Q2	–	Sell	-26,142	Closed	-$1.61M	–	4913
2021 Q1	$1.61M	Sell	26,142 -29,060	-53%	-$1.84M	﹤0.01%	2770
2020 Q4	$3.89M	Buy	+55,202	New	+$3.48M	﹤0.01%	2066

Other funds holding KROS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Jacobs Levy Equity Management

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return